AVAH
Aveanna Healthcare Holdings Inc. NASDAQ Listed Apr 28, 2021$6.94
Mkt Cap $1.5B
52w Low $3.73
48.7% of range
52w High $10.32
50d MA $6.75
200d MA $7.80
P/E (TTM)
6.0x
EV/EBITDA
10.2x
P/B
6.9x
Debt/Equity
6.9x
ROE
115.7%
P/FCF
14.3x
RSI (14)
—
ATR (14)
—
Beta
2.09
50d MA
$6.75
200d MA
$7.80
Avg Volume
1.2M
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
400 Interstate North Parkway SE · Atlanta, GA 30339 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | AMC | 0.15 | 0.17 | +10.5% | 6.34 | -4.9% | +2.8% | +2.9% | -1.5% | +0.2% | -0.2% | — |
| Nov 6, 2025 | AMC | 0.08 | 0.15 | +87.5% | 8.63 | +0.0% | +1.4% | +2.3% | +0.3% | -2.0% | -3.0% | — |
| Aug 7, 2025 | AMC | 0.04 | 0.18 | +350.0% | 5.81 | +0.3% | +5.7% | +11.2% | +6.0% | -1.2% | +0.7% | — |
| May 8, 2025 | AMC | 0.03 | 0.10 | +216.7% | 5.50 | +2.7% | -1.8% | +7.0% | +1.4% | -0.7% | +3.1% | — |
| Mar 13, 2025 | AMC | 0.00 | 0.05 | +1179.0% | 5.14 | +1.9% | +1.0% | +6.2% | -0.7% | +0.7% | -0.9% | — |
| Nov 7, 2024 | AMC | 0.01 | 0.02 | +254.9% | 5.59 | +3.2% | +4.3% | +2.1% | -2.5% | -1.0% | -4.0% | — |
| Aug 8, 2024 | AMC | 0.00 | 0.01 | +150.0% | 4.54 | +2.6% | +3.7% | -1.5% | -0.6% | -0.7% | +9.2% | — |
| May 9, 2024 | AMC | -0.05 | -0.03 | +40.0% | 2.48 | -1.2% | +0.8% | -0.8% | +3.6% | +5.8% | -2.6% | — |
| Mar 14, 2024 | AMC | -0.01 | -0.01 | -16.2% | 2.42 | -3.7% | +2.5% | -2.4% | +2.1% | -1.2% | +2.9% | — |
| Nov 9, 2023 | AMC | -0.03 | -0.03 | -12.4% | 1.52 | +2.6% | +5.3% | +0.0% | +17.5% | +1.3% | -1.3% | — |
| Aug 10, 2023 | AMC | -0.01 | -0.02 | -44.9% | 1.82 | -1.1% | +1.1% | -2.7% | -1.1% | -4.0% | -2.9% | — |
| May 11, 2023 | AMC | -0.06 | -0.05 | +16.7% | 1.09 | -2.8% | +2.8% | -4.5% | +3.7% | +9.9% | +1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 | Truist | Maintains | Hold → Hold | — | $6.22 | $6.20 | -0.3% | +3.4% | +3.1% | +1.4% | -0.1% | +0.9% |
| Mar 25 | Barclays | Maintains | Overweight → Overweight | — | $6.61 | $6.68 | +1.1% | +0.2% | -0.2% | -4.8% | +1.4% | +0.9% |
| Mar 23 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $6.52 | $6.65 | +2.0% | +2.9% | -1.5% | +0.2% | -0.2% | -4.8% |
| Mar 20 | BMO Capital | Maintains | Outperform → Outperform | — | $6.34 | $6.03 | -4.9% | +2.8% | +2.9% | -1.5% | +0.2% | -0.2% |
| Mar 20 | Truist | Maintains | Hold → Hold | — | $6.34 | $6.03 | -4.9% | +2.8% | +2.9% | -1.5% | +0.2% | -0.2% |
| Jan 16 | Barclays | Maintains | Overweight → Overweight | — | $9.76 | $9.70 | -0.6% | -5.5% | -1.0% | -1.5% | -0.8% | -2.7% |
| Jan 15 | UBS | Maintains | Neutral → Neutral | — | $9.34 | $9.44 | +1.1% | +4.5% | -5.5% | -1.0% | -1.5% | -0.8% |
| Jan 15 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $9.34 | $9.44 | +1.1% | +4.5% | -5.5% | -1.0% | -1.5% | -0.8% |
| Nov 7 | UBS | Maintains | Neutral → Neutral | — | $8.63 | $8.63 | +0.0% | +1.4% | +2.3% | +0.3% | -2.0% | -3.0% |
| Nov 7 | Truist | Maintains | Hold → Hold | — | $8.63 | $8.63 | +0.0% | +1.4% | +2.3% | +0.3% | -2.0% | -3.0% |
| Oct 28 | Jefferies | Maintains | Buy → Buy | — | $9.63 | $9.78 | +1.6% | +1.9% | +0.5% | -5.3% | -3.1% | +4.0% |
| Oct 24 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $9.12 | $9.28 | +1.8% | +3.4% | +2.1% | +1.9% | +0.5% | -5.3% |
| Oct 13 | UBS | Maintains | Neutral → Neutral | — | $8.65 | $8.77 | +1.4% | +2.0% | +5.7% | +5.2% | +1.9% | -1.3% |
| Sep 18 | JP Morgan | Upgrade | Underweight → Neutral | — | $8.08 | $8.32 | +3.0% | +4.7% | -4.3% | +3.7% | -0.1% | -0.4% |
| Aug 19 | UBS | Upgrade | Sell → Neutral | — | $7.04 | $7.43 | +5.5% | +3.3% | -1.0% | -2.2% | +6.1% | -0.5% |
| Aug 19 | Barclays | Upgrade | Equal Weight → Overweight | — | $7.04 | $7.43 | +5.5% | +3.3% | -1.0% | -2.2% | +6.1% | -0.5% |
| Aug 12 | UBS | Maintains | Sell → Sell | — | $6.83 | $6.89 | +0.9% | +6.0% | -1.2% | +0.7% | -1.7% | -0.6% |
| Aug 11 | Raymond James | Upgrade | Market Perform → Outperform | — | $6.14 | $6.53 | +6.4% | +11.2% | +6.0% | -1.2% | +0.7% | -1.7% |
| Jul 21 | Jefferies | Upgrade | Hold → Buy | — | $3.96 | $4.26 | +7.6% | +1.8% | -0.2% | +1.5% | -3.4% | +0.5% |
| Jul 16 | Truist | Maintains | Hold → Hold | — | $4.04 | $4.04 | +0.0% | -1.2% | +0.8% | -1.5% | +1.8% | -0.2% |
| May 9 | UBS | Maintains | Sell → Sell | — | $5.50 | $5.65 | +2.7% | -1.8% | +7.0% | +1.4% | -0.7% | +3.1% |
| Apr 11 | Truist | Maintains | Hold → Hold | — | $4.80 | $4.77 | -0.6% | -6.5% | +4.9% | -3.6% | +0.4% | -0.4% |
| Mar 14 | UBS | Maintains | Sell → Sell | — | $5.14 | $5.24 | +1.9% | +1.0% | +6.2% | -0.7% | +0.7% | -0.9% |
| Jan 6 | Truist | Maintains | Hold → Hold | — | $4.66 | $4.65 | -0.2% | -3.2% | -1.3% | +4.9% | -3.4% | -1.6% |
| Aug 9 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $4.54 | $4.66 | +2.6% | +3.7% | -1.5% | -0.6% | -0.7% | +9.2% |
| Aug 9 | UBS | Maintains | Sell → Sell | — | $4.54 | $4.66 | +2.6% | +3.7% | -1.5% | -0.6% | -0.7% | +9.2% |
| Aug 9 | Deutsche Bank | Maintains | Buy → Buy | — | $4.54 | $4.66 | +2.6% | +3.7% | -1.5% | -0.6% | -0.7% | +9.2% |
| Mar 18 | Deutsche Bank | Maintains | Buy → Buy | — | $2.48 | $2.45 | -1.2% | -2.4% | +2.1% | -1.2% | +2.9% | +0.0% |
| Dec 13 | JP Morgan | Downgrade | Neutral → Underweight | — | $2.34 | $2.20 | -6.0% | -1.7% | +0.0% | +3.0% | -2.1% | +11.2% |
| Aug 11 | Credit Suisse | Maintains | Underperform → Underperform | — | $1.82 | $1.80 | -1.1% | +1.1% | -2.7% | -1.1% | -4.0% | -2.9% |
| Jul 13 | Truist | Maintains | Hold → Hold | — | $1.53 | $1.50 | -2.0% | +7.2% | -4.9% | +3.8% | +2.5% | +6.0% |
| May 15 | RBC Capital | Maintains | Sector Perform → Perform | — | $1.12 | $1.13 | +0.9% | -4.5% | +3.7% | +9.9% | +1.6% | -0.8% |
| May 15 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $1.12 | $1.13 | +0.9% | -4.5% | +3.7% | +9.9% | +1.6% | -0.8% |
| May 12 | Credit Suisse | Maintains | Underperform → Underperform | — | $1.09 | $1.06 | -2.8% | +2.8% | -4.5% | +3.7% | +9.9% | +1.6% |
| May 12 | Raymond James | Downgrade | Strong Buy → Market Perform | — | $1.09 | $1.06 | -2.8% | +2.8% | -4.5% | +3.7% | +9.9% | +1.6% |
| Mar 20 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $1.30 | $1.29 | -0.8% | -12.3% | +0.0% | -12.7% | +1.4% | +5.0% |
| Mar 20 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $1.30 | $1.29 | -0.8% | -12.3% | +0.0% | -12.7% | +1.4% | +5.0% |
| Mar 17 | Truist | Maintains | Hold → Hold | — | $1.39 | $1.34 | -3.6% | -6.5% | -12.3% | +0.0% | -12.7% | +1.4% |
| Jan 27 | Credit Suisse | Downgrade | Neutral → Underperform | — | $1.31 | $1.30 | -0.8% | -3.1% | -5.5% | +1.7% | -0.8% | +0.8% |
| Nov 21 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $0.78 | $0.79 | +1.9% | +1.4% | -3.0% | -3.5% | +4.1% | -5.8% |
| Nov 17 | Credit Suisse | Downgrade | Outperform → Neutral | — | $0.80 | $0.77 | -4.0% | +10.9% | -12.9% | +1.4% | -3.0% | -3.5% |
| Nov 16 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $0.88 | $0.88 | +0.0% | -8.9% | +10.9% | -12.9% | +1.4% | -3.0% |
| Nov 11 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $0.96 | $0.98 | +1.6% | +3.7% | -3.9% | -8.3% | -8.9% | +10.9% |
| Aug 19 | Barclays | Maintains | Overweight → Overweight | — | $2.13 | $2.11 | -0.9% | -8.9% | +3.1% | -4.0% | +0.5% | +9.3% |
| Aug 15 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $2.14 | $2.14 | +0.0% | -1.4% | +0.0% | -1.4% | +2.4% | -8.9% |
| Jul 22 | Jefferies | Downgrade | Buy → Hold | — | $2.23 | $2.13 | -4.5% | -9.4% | -2.5% | +10.2% | -3.2% | +1.4% |
| Jul 5 | Truist | Downgrade | Buy → Hold | — | $2.37 | $2.22 | -6.3% | +0.4% | +0.8% | +3.8% | +0.8% | -3.2% |
| Jun 21 | Stephens & Co. | Downgrade | Overweight → Equal Weight | — | $2.69 | $2.65 | -1.5% | -17.5% | +6.8% | +14.3% | -3.0% | -3.0% |
| Mar 31 | RBC Capital | Maintains | Outperform → Outperform | — | $3.77 | $3.75 | -0.5% | -9.5% | +0.3% | -2.3% | -3.0% | -0.6% |
| Mar 31 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $3.77 | $3.75 | -0.5% | -9.5% | +0.3% | -2.3% | -3.0% | -0.6% |
No insider trades available.
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
This 8-K Regulation FD disclosure provides non-binding guidance that won't trigger liability, suggesting management is communicating material information carefully to avoid legal exposure while maintaining transparency with investors.
Mar 20
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
AVAH disclosed annual financial results showing operational performance in home care services, which investors should monitor for revenue growth, profitability trends, and competitive positioning in the medically complex patient care market.
Mar 19
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
AVAH completed a significant acquisition, which could drive revenue growth and strategic expansion, but investors should monitor integration execution and potential dilution from the deal structure.
Mar 12
8-K · 5.02
!!! Very High
Aveanna Healthcare Holdings Inc. -- 8-K 5.02: Executive Change
Aveanna Healthcare's Class I director Robert M. Williams resigned, representing a leadership change that investors should monitor for potential impacts on board composition and governance.
Feb 27
8-K · 5.02
!!! Very High
Aveanna Healthcare Holdings Inc. -- 8-K 5.02: Executive Change
Aveanna Healthcare's director Jeff Shaner resigned effective February 17, 2026, representing a minor leadership change that may have limited immediate impact on the company's operations or strategic direction.
Feb 20
Data updated apr 24, 2026 7:53pm
· Source: massive.com